pentoxifylline has been researched along with Vitiligo in 2 studies
Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saki, N | 1 |
| Sheikhi Ghayur, E | 1 |
| Heiran, A | 1 |
| Gholami, M | 1 |
| Alipour, S | 1 |
| Rubio, FA | 1 |
| Robayna, G | 1 |
| Pizarro, A | 1 |
| de Lucas, R | 1 |
| Herranz, P | 1 |
| Casado, M | 1 |
1 trial available for pentoxifylline and Vitiligo
| Article | Year |
|---|---|
Topical pentoxifylline can be an effective and safe adjunctive therapy to NBUVB therapy in treating vitiligo: A split-side clinical trial.
Topics: Administration, Topical; Combined Modality Therapy; Humans; Pentoxifylline; Treatment Outcome; Ultra | 2022 |
1 other study available for pentoxifylline and Vitiligo
| Article | Year |
|---|---|
Actinic granuloma and vitiligo treated with pentoxifylline.
Topics: Aged; Granuloma Annulare; Humans; Male; Pentoxifylline; Skin; Sunlight; Vitiligo | 1998 |